R667 Uses, Dosage, Side Effects and more
R667 is an orally active, gamma selective retinoid agonist that shows promise as a treatment for emhysema, as it has, in animal models, promoted structural lung repair and functional improvement with fewer side effects. It is currently in Phase II Trials for emphysema secondary to alpha-1 antitrypsindeficiency.
R667 is an orally active, gamma selective retinoid agonist that shows promise as a treatment for emhysema.
| Attribute | Details |
|---|---|
| Trade Name | R667 |
| Generic | R667 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in emphysema.
How R667 works
Gamma-selective retinoic acid receptor agonist.
Toxicity
Well tolerated in patients with emphysema. no safety concerns have been identified.
